Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-20-032863

CEO and Chairman bought 430,000 shares at $10.00 ($4,300,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Chen Bihua CEO and Chairman 2020-10-22 Purchase +430,000 $10.00 $4,300,000 430,000 I
Open-market purchases · 430,000 sh · avg $10.00 · $4,300,000
Loading xslF345X03/ownership.xml…